Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids
NBER Working Paper No. 23031
---- Acknowledgments ----
We would like to thank seminar participants at the Conference of the American Society of Health Economists and the APPAM Fall Research Conference for helpful comments, especially from our discussants Dean Lillard and Melinda Buntin. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.